Cargando…
Murepavadin, a Small Molecule Host Defense Peptide Mimetic, Activates Mast Cells via MRGPRX2 and MrgprB2
Pseudomonas aeruginosa is a frequent cause of hospital-acquired wound infection and is difficult to treat because it forms biofilms and displays antibiotic resistance. Previous studies in mice demonstrated that mast cells (MCs) not only contribute to P. aeruginosa eradication but also promote wound...
Autores principales: | Amponnawarat, Aetas, Chompunud Na Ayudhya, Chalatip, Ali, Hydar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261236/ https://www.ncbi.nlm.nih.gov/pubmed/34248979 http://dx.doi.org/10.3389/fimmu.2021.689410 |
Ejemplares similares
-
Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist
por: Bawazir, Maram, et al.
Publicado: (2022) -
MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants
por: Chompunud Na Ayudhya, Chalatip, et al.
Publicado: (2021) -
Substance P Serves as a Balanced Agonist for MRGPRX2 and a Single Tyrosine Residue Is Required for β-Arrestin Recruitment and Receptor Internalization
por: Chompunud Na Ayudhya, Chalatip, et al.
Publicado: (2021) -
GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells via MRGPRX2 and MRGPRB2
por: Thapaliya, Monica, et al.
Publicado: (2022) -
Identification of Gain and Loss of Function Missense Variants in MRGPRX2’s Transmembrane and Intracellular Domains for Mast Cell Activation by Substance P
por: Chompunud Na Ayudhya, Chalatip, et al.
Publicado: (2019)